4//SEC Filing
Deignan Charles A. 4
Accession 0001209191-23-050162
CIK 0001539029other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:30 PM ET
Size
5.6 KB
Accession
0001209191-23-050162
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-09-18+100,000→ 100,000 totalExercise: $0.85Exp: 2033-09-18→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]One-third of the shares underlying this option vest on September 18, 2024 and the balance of the shares vest in a series of 24 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001664690
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 4:30 PM ET
- Size
- 5.6 KB